Caseware UK (AP4) 2024.0.164 2024.0.164 2024-07-312024-07-312023-08-01falseNo description of principal activity22truetrueThe members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.false 11465323 2023-08-01 2024-07-31 11465323 2022-08-01 2023-07-31 11465323 2024-07-31 11465323 2023-07-31 11465323 c:Director1 2023-08-01 2024-07-31 11465323 c:Director2 2023-08-01 2024-07-31 11465323 d:CurrentFinancialInstruments 2024-07-31 11465323 d:CurrentFinancialInstruments 2023-07-31 11465323 d:Non-currentFinancialInstruments 2024-07-31 11465323 d:Non-currentFinancialInstruments 2023-07-31 11465323 d:CurrentFinancialInstruments d:WithinOneYear 2024-07-31 11465323 d:CurrentFinancialInstruments d:WithinOneYear 2023-07-31 11465323 d:Non-currentFinancialInstruments d:AfterOneYear 2024-07-31 11465323 d:Non-currentFinancialInstruments d:AfterOneYear 2023-07-31 11465323 d:Non-currentFinancialInstruments d:BetweenOneTwoYears 2024-07-31 11465323 d:Non-currentFinancialInstruments d:BetweenOneTwoYears 2023-07-31 11465323 d:Non-currentFinancialInstruments d:BetweenTwoFiveYears 2024-07-31 11465323 d:Non-currentFinancialInstruments d:BetweenTwoFiveYears 2023-07-31 11465323 d:Non-currentFinancialInstruments d:MoreThanFiveYears 2024-07-31 11465323 d:Non-currentFinancialInstruments d:MoreThanFiveYears 2023-07-31 11465323 d:ShareCapital 2024-07-31 11465323 d:ShareCapital 2023-07-31 11465323 d:RetainedEarningsAccumulatedLosses 2024-07-31 11465323 d:RetainedEarningsAccumulatedLosses 2023-07-31 11465323 c:OrdinaryShareClass1 2023-08-01 2024-07-31 11465323 c:OrdinaryShareClass1 2024-07-31 11465323 c:OrdinaryShareClass1 2023-07-31 11465323 c:FRS102 2023-08-01 2024-07-31 11465323 c:AuditExempt-NoAccountantsReport 2023-08-01 2024-07-31 11465323 c:FullAccounts 2023-08-01 2024-07-31 11465323 c:PrivateLimitedCompanyLtd 2023-08-01 2024-07-31 11465323 2 2023-08-01 2024-07-31 11465323 e:PoundSterling 2023-08-01 2024-07-31 xbrli:shares iso4217:GBP xbrli:pure

Registered number: 11465323









YOUR GP CIRCLE LIMITED







UNAUDITED

FINANCIAL STATEMENTS

INFORMATION FOR FILING WITH THE REGISTRAR

FOR THE YEAR ENDED 31 JULY 2024

 
YOUR GP CIRCLE LIMITED
REGISTERED NUMBER: 11465323

BALANCE SHEET
AS AT 31 JULY 2024

2024
2023
Note
£
£

  

Current assets
  

Debtors: amounts falling due within one year
 4 
48,692
53,534

Cash at bank and in hand
  
91,803
97,550

  
140,495
151,084

Creditors: amounts falling due within one year
 5 
(16,569)
(14,288)

Net current assets
  
 
 
123,926
 
 
136,796

Total assets less current liabilities
  
123,926
136,796

Creditors: amounts falling due after more than one year
 6 
(30,293)
(35,551)

  

Net assets
  
93,633
101,245


Capital and reserves
  

Called up share capital 
 8 
100
100

Profit and loss account
  
93,533
101,145

  
93,633
101,245


Page 1

 
YOUR GP CIRCLE LIMITED
REGISTERED NUMBER: 11465323
    
BALANCE SHEET (CONTINUED)
AS AT 31 JULY 2024

The directors consider that the Company is entitled to exemption from audit under section 477 of the Companies Act 2006 and members have not required the Company to obtain an audit for the year in question in accordance with section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements.

The financial statements have been prepared in accordance with the provisions applicable to companies subject to the small companies regime and in accordance with the provisions of FRS 102 Section 1A - small entities.

The financial statements have been delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The Company has opted not to file the statement of income and retained earnings in accordance with provisions applicable to companies subject to the small companies' regime.

The financial statements were approved and authorised for issue by the board and were signed on its behalf on 28 April 2025.




Dr Neha Sahay
Dr Rahul Sahay
Director
Director

The notes on pages 3 to 6 form part of these financial statements.

Page 2

 
YOUR GP CIRCLE LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 JULY 2024

1.


General information

The Company is a private company, limited by shares, incorporated and domiciled in England within the United Kingdom, registration number 11465323.  The Company's registered office is Sterling House, 71 Francis Road, Edgbaston, Birmingham, B16 8SP. 
The financial statements are presented in sterling which is the functional currency of the company and the financial statements are rounded to the nearest £1.

2.Accounting policies

 
2.1

Basis of preparation of financial statements

The financial statements have been prepared under the historical cost convention unless otherwise specified within these accounting policies and in accordance with FRS 102 'The Financial Reporting Standard applicable in the UK and the Republic of Ireland' and the requirements of the Companies Act 2006. The disclosure requirements of Section 1A of FRS 102 have been applied other than where additional disclosure is required to show a true and fair view.

Cash flow
Under Financial Reporting Standard 102, the company is exempt from the requirement to prepare a cash flow statement on the grounds that it qualifies as a small company.

The following principal accounting policies have been applied:

 
2.2

Going concern

The directors have prepared the accounts on a going concern basis.

 
2.3

Revenue

Revenue is recognised to the extent that it is probable that the economic benefits will flow to the Company and the revenue can be reliably measured. Revenue is measured as the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes. The following criteria must also be met before revenue is recognised:

Rendering of services

Revenue from a contract to provide services is recognised in the period in which the services are provided in accordance with the stage of completion of the contract when all of the following conditions are satisfied:
the amount of revenue can be measured reliably;
it is probable that the Company will receive the consideration due under the contract;
the stage of completion of the contract at the end of the reporting period can be measured reliably; and
the costs incurred and the costs to complete the contract can be measured reliably.

 
2.4

Interest income

Interest income is recognised in profit or loss using the effective interest method.

Page 3

 
YOUR GP CIRCLE LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 JULY 2024

2.Accounting policies (continued)

 
2.5

Finance costs

Finance costs are charged to profit or loss over the term of the debt using the effective interest method so that the amount charged is at a constant rate on the carrying amount. Issue costs are initially recognised as a reduction in the proceeds of the associated capital instrument.

 
2.6

Borrowing costs

All borrowing costs are recognised in profit or loss in the year in which they are incurred.

 
2.7

Taxation

Tax is recognised in profit or loss except that a charge attributable to an item of income and expense recognised as other comprehensive income or to an item recognised directly in equity is also recognised in other comprehensive income or directly in equity respectively.

The current income tax charge is calculated on the basis of tax rates and laws that have been enacted or substantively enacted by the balance sheet date in the countries where the Company operates and generates income.


 
2.8

Debtors

Short-term debtors are measured at transaction price, less any impairment. Loans receivable are measured initially at fair value, net of transaction costs, and are measured subsequently at amortised cost using the effective interest method, less any impairment.

 
2.9

Cash and cash equivalents

Cash is represented by cash in hand and deposits with financial institutions repayable without penalty on notice of not more than 24 hours. Cash equivalents are highly liquid investments that mature in no more than three months from the date of acquisition and that are readily convertible to known amounts of cash with insignificant risk of change in value.

 
2.10

Creditors

Short-term creditors are measured at the transaction price. Other financial liabilities, including bank loans, are measured initially at fair value, net of transaction costs, and are measured subsequently at amortised cost using the effective interest method.


3.


Employees

The average monthly number of employees, including directors, during the year was 2 (2023 - 2).

Page 4

 
YOUR GP CIRCLE LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 JULY 2024

4.


Debtors

2024
2023
£
£


Other debtors
48,692
53,534

48,692
53,534



5.


Creditors: Amounts falling due within one year

2024
2023
£
£

Bank loans
5,000
5,000

Other creditors
9,979
5,856

Accruals and deferred income
1,590
3,432

16,569
14,288



6.


Creditors: Amounts falling due after more than one year

2024
2023
£
£

Bank loans
30,293
35,551

30,293
35,551


Page 5

 
YOUR GP CIRCLE LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 JULY 2024

7.


Loans


Analysis of the maturity of loans is given below:


2024
2023
£
£

Amounts falling due within one year

Bank loans
5,000
5,000


5,000
5,000

Amounts falling due 1-2 years

Bank loans
5,000
5,000


5,000
5,000

Amounts falling due 2-5 years

Bank loans
15,000
15,000


15,000
15,000

Amounts falling due after more than 5 years

Bank loans
10,293
15,551

10,293
15,551

35,293
40,551



8.


Share capital

2024
2023
£
£
Allotted, called up and fully paid



100 (2023 - 100) Ordinary shares of £1.00 each
100
100



9.


Related party transactions

As at the balance sheet date £6,245 (2023: £4,522) was due to the directors. This loan is interest free and repayable on demand.

 
Page 6